Resveratrol and cardiovascular system—the unfulfilled hopes

Autor: Joanna Banach, Grzegorz Grześk, Łukasz Wołowiec, Małgorzata Chudzińska, Sławomir Sielski, Daniel Rogowicz, Anna Sinkiewicz, Robert Bujak
Rok vydání: 2020
Předmět:
Zdroj: Irish Journal of Medical Science (1971 -). 190:981-986
ISSN: 1863-4362
0021-1265
DOI: 10.1007/s11845-020-02441-x
Popis: Resveratrol is a natural polyphenolic compound with a stilbene structure endowed with multiple health-promoting effects. Among phenolic compounds, resveratrol is assigned a leading role in the health-promoting effects of red wine. The aim of the study was to assess the effect of resveratrol on the cardiovascular system in the experimental and clinical studies conducted so far. Moreover, the paper discusses the results of the most recent meta-analyses assessing resveratrol’s therapeutic effect on the cardiovascular system in humans. In animal and preclinical studies, resveratrol has demonstrated a wide physiological and biochemical spectrum of activity, including antioxidant, anti-inflammatory, antiplatelet, and anticoagulant activities, which translated into its health-promoting effects on the cardiovascular system. The performed meta-analyses allow to confirm such an impact, however, after the assessment with the use of the SYRCLE’s tool, these studies are burdened with a high risk of bias, and the results are not clearly presented. Despite numerous articles and clinical studies, the convincing beneficial mechanisms of resveratrol as well as its health-promoting effects in cardiovascular diseases have not been clearly confirmed in humans. Therefore, there is a need for further clinical studies, especially randomized, double-blind, placebo-controlled trials to objectively confirm the possible health-promoting effects of this substance and to determine both the efficacy and safety, and possible therapeutic potential.
Databáze: OpenAIRE
Externí odkaz: